GlaxoSmithKline, Teva, Takeda Investing in Global Sustainability Performance with the Responsible Health Initiative

February 6, 2019 EcoVadis EN


Three leading health and pharmaceutical companies -- GlaxoSmithKline, Teva, Takeda – and EcoVadis, the leading provider of sustainability risk and performance ratings for global supply chains, today announced the launch of the Responsible Health Initiative. The mission of the new sector initiative is to use collaboration and technology to improve the visibility, efficiency and sustainability impact of the global health supply chain.


About the Author

EcoVadis EN

EcoVadis is a purpose-driven company whose mission is to provide the world's most trusted business sustainability ratings. Businesses of all sizes rely on EcoVadis’ expert intelligence and evidence-based ratings to manage risk and compliance, drive decarbonization, and improve the sustainability performance of their business and value chain. Its AI-powered risk mapping, actionable scorecards, benchmarks, carbon action tools, and insights guide a resilience and improvement journey for environmental, social and ethical practices across 200 industry categories and 175 countries.

Follow on Twitter Follow on Linkedin Visit Website More Content by EcoVadis EN
Previous Article
Improving the Lot of the Global Supply-Chain Worker
Improving the Lot of the Global Supply-Chain Worker

EcoVadis is another entity to employ technology to monitor factory conditions. It provides an online platfo...

Next Article
Less Than 10 Percent of Global Companies Report on Business Ethics KPIs, According to New EcoVadis Anti-Corruption Report
Less Than 10 Percent of Global Companies Report on Business Ethics KPIs, According to New EcoVadis Anti-Corruption Report

EcoVadis has published a new anti-corruption study that reports how businesses manage critical ethical issu...